DOSE-RESPONSE RELATIONSHIPS OF ACE-INHIBITORS AND ANGIOTENSIN-II BLOCKERS

被引:13
作者
BRUNNER, HR
NUSSBERGER, J
WAEBER, B
机构
关键词
ANGIOTENSIN I; ANGIOTENSIN II; PRESSURE RESPONSE TO ANGIOTENSIN; PLASMA DRUG LEVELS;
D O I
10.1093/eurheartj/15.suppl_D.123
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is difficult to establish dose-response relationships for ACE inhibitors in patients with hypertension or congestive heart failure This has led to the widely held opinion that the effects of ACE inhibitors are hardly dose dependent The purpose of this short discussion is to demonstrate that this class of compounds, as well as the more recent angiotensin II receptor antagonists, exhibit some very clear dose-response relationships when these are evaluated in normal volunteers based on the mechanisms for which they were designed. Characterization of these dose-response curves is important in order to use these drugs at their optimal dose and to obtain the maximal therapeutic benefit.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 33 条
  • [1] ATKINSON AB, 1979, LANCET, V2, P836
  • [2] BRUNNER HR, 1973, LANCET, V2, P1045
  • [3] BRUNNER HR, 1983, HYPERTENSION, V5, P101
  • [4] CHIU AT, 1990, J PHARMACOL EXP THER, V252, P711
  • [5] ORAL-ADMINISTRATION OF DUP-753, A SPECIFIC ANGIOTENSIN-II RECEPTOR ANTAGONIST, TO NORMAL-MALE VOLUNTEERS - INHIBITION OF PRESSOR-RESPONSE TO EXOGENOUS ANGIOTENSIN-I AND ANGIOTENSIN-II
    CHRISTEN, Y
    WAEBER, B
    NUSSBERGER, J
    PORCHET, M
    BORLAND, RM
    LEE, RJ
    MAGGON, K
    SHUM, L
    TIMMERMANS, PBMWM
    BRUNNER, HR
    [J]. CIRCULATION, 1991, 83 (04) : 1333 - 1342
  • [6] ENALAPRIL WORLDWIDE EXPERIENCE
    DAVIES, RO
    IRVIN, JD
    KRAMSCH, DK
    WALKER, JF
    MONCLOA, F
    [J]. AMERICAN JOURNAL OF MEDICINE, 1984, 77 (2A) : 23 - 35
  • [7] VALUE OF DIFFERENT CLINICAL AND BIOCHEMICAL CORRELATES TO ASSESS ANGIOTENSIN-CONVERTING ENZYME-INHIBITION
    DELACRETAZ, E
    NUSSBERGER, J
    PUCHLER, K
    WOOD, AJ
    ROBINSON, PR
    WAEBER, B
    BRUNNER, HR
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (03) : 479 - 485
  • [8] DRAYER JIM, 1986, HYPERTENSION S3, V5, P108
  • [9] EDWARDS CRW, 1985, LANCET, V1, P30
  • [10] FERGUSON RK, 1984, AM J MED, V77, P690, DOI 10.1016/0002-9343(84)90367-X